Edinburgh, United Kingdom
Wobble Genomics Ltd, founded in 2021, is a UK-based leader in the biotechnology and pharmaceutical industries, pioneering advancements in long-read RNA sequencing. With its "Wobble Genomics is a pioneering healthcare and biotechnology company specialising in long-read RNA sequencing." slogan, the company emphasizes its innovation-led focus on enhancing the detection of low-abundance RNA sequences.
Its proprietary Level-Up biochemical technology stands out, enabling comprehensive capture of unique full-length RNA sequences across diverse samples. Complemented by TAMA bioinformatic technology, Wobble Genomics excels in optimizing low-level signal identification, utilizing RNA biology for more profound data insights.
In its latest funding round on 01 March 2024, the company secured a substantial £8.46M in seed investment. Esteemed backers include IQ Capital, Mercia, Edinburgh Innovations, Business Growth Fund, and Eos Advisory, marking robust investor confidence in its potential to innovate and grow.
